| First Author | Liang Y | Year | 2024 |
| Journal | Front Immunol | Volume | 15 |
| Pages | 1361596 | PubMed ID | 38690266 |
| Mgi Jnum | J:347768 | Mgi Id | MGI:7627611 |
| Doi | 10.3389/fimmu.2024.1361596 | Citation | Liang Y, et al. (2024) Protection of neutrophils by bone marrow mesenchymal stromal cells is enhanced by tumor-associated inflammatory cytokines. Front Immunol 15:1361596 |
| abstractText | Mesenchymal stromal/stem cells (MSCs), which are distributed in many tissues including bone marrow, have been reported to play a critical role in tumor development. While bone marrow, the primary site for hematopoiesis, is important for establishing the immune system, whether MSCs in the bone marrow can promote tumor growth via influencing hematopoiesis remains unclear. We observed that the numbers of MSCs and neutrophils were increased in bone marrow in tumor-bearing mice. Moreover, co-culture assay showed that MSCs strongly protected neutrophils from apoptosis and induced their maturation. G-CSF and GM-CSF have been well-documented to be associated with neutrophil formation. We found a remarkably increased level of G-CSF, but not GM-CSF, in the supernatant of MSCs and the serum of tumor-bearing mice. The G-CSF expression can be enhanced with inflammatory cytokines (IFNgamma and TNFalpha) stimulation. Furthermore, we found that IFNgamma and TNFalpha-treated MSCs enhanced their capability of promoting neutrophil survival and maturation. Our results indicate that MSCs display robustly protective effects on neutrophils to contribute to tumor growth in bone niches. |
